4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

J. Jacobson,B. Sleebs, K. Jarman, W. Nguyen,T. Mota, L. Harty,G. Khoury, N. Tay,P. Cameron,S. Lewin,D.F.J. Purcell

Journal of Virus Eradication(2017)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要